Patents by Inventor Martin Biendl

Martin Biendl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9527860
    Abstract: The present invention relates to certain chromane-like cyclic prenylflavonoids, in particular the compounds of formulae (I), (II) and (III) as described and defined herein, for use in the treatment or prevention of a neurological disorder, as well as their use in promoting neuronal differentiation, neurite outgrowth and neuroprotection.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: December 27, 2016
    Inventors: Ludwig Aigner, Eleni Oberbauer-Hofmann, Sébastien Couillard-Despres, Francisco Javier Rivera, Herbert Riepl, Corinna Urmann, Martin Biendl
  • Publication number: 20140349919
    Abstract: The present invention relates to certain chromane-like cyclic prenylflavonoids, in particular the compounds of formulae (I), (II) and (III) as described and defined herein, for use in the treatment or prevention of a neurological disorder, as well as their use in promoting neuronal differentiation, neurite outgrowth and neuroprotection.
    Type: Application
    Filed: June 15, 2012
    Publication date: November 27, 2014
    Inventors: Ludwig Aigner, Eleni Oberbauer-Hofmann, Sébastien Couillard-Despres, Francisco Javier Rivera, Herbert Riepl, Corinna Urmann, Martin Biendl
  • Patent number: 8067622
    Abstract: The present invention relates to an efficient method for producing naringenin derivatives from xanthohumol or derivatives thereof. In particular, the method according to the present invention provides the production of isoxanthohumol, for example also in enantiomer-enriched form, from xanthohumol and subsequent demethylation of isoxanthohumol according to specific procedures obtaining corresponding naringenin derivatives, such as, in particular, 8-prenylnaringenin.
    Type: Grant
    Filed: February 7, 2006
    Date of Patent: November 29, 2011
    Assignee: Hopsteiner-Hallertauer Hopfenveredelungsgesellschaft M.B.H.
    Inventors: Heike Wilhelm, Ludger A. Wessjohann, Martin Biendl
  • Publication number: 20090227806
    Abstract: The present invention relates to an efficient method for producing naringenin derivatives from xanthohumol or derivatives thereof. In particular, the method according to the present invention provides the production of isoxanthohumol, for example also in enantiomer-enriched form, from xanthohumol and subsequent demethylation of isoxanthohumol according to specific procedures obtaining corresponding naringenin derivatives, such as, in particular, 8-prenylnaringenin.
    Type: Application
    Filed: February 7, 2006
    Publication date: September 10, 2009
    Inventors: Heike Wilhelm, Ludger A. Wessojohann, Martin Biendl
  • Patent number: 6867332
    Abstract: A process is specified by which the xanthohumol present in hops can be isolated in high yield in an economical manner. In the process an ethanol pure resin extract is first extracted with a liquid or supercritical solvent in which the xanthohumol is insoluble and the resultant extraction residue is first washed with a first solvent mixture and then the extraction residue which has been washed with the first solvent mixture is, after removing the first solvent mixture, extracted with a second solvent mixture, the first solvent mixture having a higher polarity than the second solvent mixture. The hop extract produced from the second solvent mixture has a xanthohumol content of at least 85% by weight.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: March 15, 2005
    Assignee: Hallertauer Hopfenveredelungsgesellschaft m.b.H.
    Inventors: Martin Biendl, Hans Becker, Aslieh Nookandeh